Little Bellies, Australian Snack Food Brand wins case against Aldi

SYDNEY,Dec. 19,2024-- In a legal first in Australia,founder-owned baby and snack food brand,Little Bellies,a brand owned by Every Bite Counts has set an important precedent in their win on copyright i

"You've Got a Friend" Charity Concert Aims to Promote Mental Wellness

HONG KONG,Dec. 19,2024-- The "You\'ve Got a Friend" charity concert,organized by the Hong Kong Mental Wellness Association,will take placefrom April 9 to 11,2025,at the Rita Tong Liu Drama T

S2C Launches Prodigy S8-100 Series: 100M Gate FPGA Prototyping for AI and HPC

SAN JOSE,Calif.,Dec. 19,2024--S2C,a global leader in FPGA-based prototyping solutions,announces its Prodigy S8-100 Logic System,the latest addition to the eighth-generation family,is shipping and depl

Dr. Sanjay Sharma: A Visionary Leader in Finance and Philanthropy

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

ADELA,an international phase III study being conducted across multiple countries,combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations,aiming to delay dis

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

New collaboration deliverscashless services,as well as access to expedited appointments for outpatient cancer treatment services and independent cancer medical consultation,ensuringcomprehensive andco

Bota Bio debuted the 2024 FiE and launched its subsidiary HeliaGenesis, focusing on food and nutrition industries

SAN FRANCISCO and HANGZHOU,China,Dec. 12,2024-- The 31st Food Ingredients Europe (referred to as FiE) concluded successfully from November 19th to 21st,2024,in Frankfurt,Germany. The event brought to

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

- A Milestone in Preventive Healthcare and Technological Innovation in Long An TÂN AN CITY,Vietnam,Dec. 12,2024-- Core8 Group,an Australian leader in high-tech and biotech innovation,has unveile

Porton Pharma Solutions and Aojin Life Sciences Announce Strategic Collaboration to Advance XDC Conjugate Drugs for Dual IND Filings in China and the U.S.

CHONGQING,China,Dec. 12,2024-- Recently,Porton Pharma Solutions Ltd. ("Porton") announced a strategic partnership with Aojin Life Sciences (Yixing) Co.,Ltd. ("Aojin Life Sciences")

2024 SABCS｜Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

YANTAI,China,Dec. 13,2024-- On the morning of December 12,2024 (UTC-6),at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),Reme